Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pancreatology. 2019 Jul;19(5):658-664. doi: 10.1016/j.pan.2019.05.467. Epub 2019 Jun 8.
Percutaneous catheter drainage (PCD) is effective initial strategy in the step-up approach of management of acute pancreatitis (AP). The objective of this study was to identify factors associated with outcomes after PCD and develop a predictive model.
In a prospective observational study between July 2016 and Nov 2017, 101 consecutive AP patients were treated using a "step-up approach" in which PCD was used as the first step. We evaluated the association between success of PCD (survival without necrosectomy) and baseline parameters viz. etiology, demography, severity scores, C-reactive protein (CRP), and intra-abdominal pressure (IAP), morphologic characteristics on computed tomography (CT) [percentage of necrosis, CT severity index (CTSI), characteristics of collection prior to PCD (volume, site and solid component of the collection), PCD parameters (initial size, maximum size, number and duration of drainage) and factors after PCD insertion (fall in IAP, reduction in volume of collection).
Among 101 patients, 51 required PCD. The success rate of PCD was 66.66% (34/51). Four patients required additional surgical necrosectomy after PCD. Overall mortality was 29.4% (15/51). Multivariate analysis showed percentage of volume reduction of fluid collection (p = 0.016) and organ failure (OF) resolution (p = 0.023) after one week of PCD to be independent predictors of success of PCD. A predictive model based on these two factors resulted in area under curve (AUROC) of 0.915. Nomogram was developed with these two factors to predict the probability of success of PCD.
Organ failure resolution and reduction in volume of collection after one week of PCD are significant predictors of successful PCD outcomes in patients with fluid collection following AP.
经皮导管引流(PCD)是急性胰腺炎(AP)治疗中逐步升级策略的有效初始策略。本研究的目的是确定与 PCD 后结果相关的因素,并建立预测模型。
在 2016 年 7 月至 2017 年 11 月期间进行的一项前瞻性观察研究中,101 例 AP 患者采用“逐步升级方法”进行治疗,其中 PCD 作为第一步。我们评估了 PCD 成功(无需坏死切除术即可存活)与基线参数之间的关联,包括病因、人口统计学、严重程度评分、C 反应蛋白(CRP)和腹腔内压(IAP)、计算机断层扫描(CT)上的形态特征[坏死百分比、CT 严重指数(CTSI)、PCD 前收集的特征(体积、部位和收集的固体成分)、PCD 参数(初始大小、最大大小、引流的数量和持续时间)以及 PCD 插入后因素(IAP 下降、收集体积减少)。
在 101 例患者中,51 例需要 PCD。PCD 的成功率为 66.66%(34/51)。4 例患者在 PCD 后需要额外的手术坏死切除术。总死亡率为 29.4%(15/51)。多变量分析显示,PCD 后一周内液体收集体积减少百分比(p=0.016)和器官衰竭(OF)缓解(p=0.023)是 PCD 成功的独立预测因素。基于这两个因素的预测模型得出的曲线下面积(AUROC)为 0.915。使用这两个因素开发了列线图,以预测 PCD 成功的概率。
PCD 后一周内 OF 缓解和收集体积减少是 AP 后有液体收集患者 PCD 结果成功的重要预测因素。